Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series

Use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) in near-fatal asthma: a case series

Authors

Keywords:

Status asthmaticus, Near-Fatal Asthma, Extracorporeal Membrane Oxygenation, Mechanical Power, Case Series

Abstract

Introduction: Status asthmaticus (SA) and near-fatal asthma (NFA) are life-threatening conditions that continue to present a management challenge for physicians. Extracorporeal Membrane Oxygenation (ECMO) has been employed as a last resort in treating these patients.

Case presentation: We described six patients who were admitted to the ICU for near-fatal asthma (NFA) and received ECMO treatment at a high-complexity institution in Cali, Colombia, between 2015 and 2019. All patients are registered in the ELSO registry. Baseline patient characteristics, arterial blood gases (ABG), ventilatory parameters, and complications were collected as specified in the ELSO registry form. Efficacy was analyzed in terms of the improvement in respiratory acidosis, the number of ventilator-free days (VFD), and a reduction in mechanical power (MP). MP, which refers to the energy associated with the mechanical forces involved in breathing and the functioning of the respiratory system, was calculated using a mathematical formula. Safety was evaluated based on the incidence of complications. After 12 hours of ECMO, we achieved a correction of respiratory acidosis, a significant decrease in all ventilatory parameters, and a reduction in MP ranging from 52.8% to 89%. There was one mortality. Among the five surviving patients, all except one, who required a tracheostomy, had a high VFD score, with a mode of 26 days, demonstrating a reduction in ventilation time.

Conclusion: Further randomized controlled trials are needed to fully understand the efficacy and safety profiles of ECMO in SA/NFA. MP is being widely used to achieve safer ventilation, and although more data is required, it appears to be a promising option for evaluating the risk of developing VILI and the success of the therapy.

References

Louie S, Morrissey BM, Kenyon NJ, Albertson TE, Avdalovic M. The Critically Ill Asthmatic—from ICU to Discharge. Clin Rev Allergy Immunol. 2012 Aug 1;43(1):30–44.

Leatherman J. Mechanical Ventilation for Severe Asthma. Chest 2015;147(6):1671–80.

Holley AD, Boots RJ. Review article: Management of acute severe and near-fatal asthma. Emerg Med Australas 2009;21(4):259–68.

Kaur BP, Lahewala S, Arora S, Agnihotri K, Panaich SS, Secord E, et al. Asthma: Hospitalization Trends and Predictors of In-Hospital Mortality and Hospitalization Costs in the USA (2001-2010). Int Arch Allergy Immunol 2016;168(2):71–8.

Mikkelsen ME, Woo YJ, Sager JS, Fuchs BD, Christie JD. Outcomes using extracorporeal life support for adult respiratory failure due to status asthmaticus. ASAIO J 2009;55(1):47-52.

Tonna JE, Abrams D, Brodie D, Greenwood JC, Mateo-Sidron JAR, Usman A, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J 2021;67(6):601–10.

Marini JJ. How I optimize power to avoid VILI. Crit Care 2019;23(1):326.

Chiu LC, Lin SW, Chuang LP, Li HH, Liu PH, Tsai FC, et al. Mechanical power during extracorporeal membrane oxygenation and hospital mortality in patients with acute respiratory distress syndrome. Crit Care 2021;25:13.

ECLS Registry Forms | ELSO | ECMO | Extracorporeal Life Support (Internet). (cited 2023 Oct 3). Available from: https://www.elso.org/registry/datadefinitions,forms,instructions.aspx

Yeo HJ, Kim D, Jeon D, Kim YS, Rycus P, Cho WH. Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry. Crit Care 2017;21(1):297.

Vyas A, Bishop MA. Extracorporeal Membrane Oxygenation in Adults. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2023 (cited 2023 Oct 3). Available from: http://www.ncbi.nlm.nih.gov/books/NBK576426/

Gattinoni L, Marini JJ, Collino F, Maiolo G, Rapetti F, Tonetti T, et al. The future of mechanical ventilation: lessons from the present and the past. Crit Care 2017;21(1):183.

Marini JJ, Rocco PRM. Which component of mechanical power is most important in causing VILI? Crit Care 2020;24(1):39.

Giosa L, Busana M, Pasticci I, Bonifazi M, Macrì MM, Romitti F, et al. Mechanical power at a glance: a simple surrogate for volume-controlled ventilation. Intensive Care Med Exp 2019;7:61.

Hurley JJ, Hensley JL. Physiology, Airway Resistance. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2023 (cited 2023 Oct 31). Available from: http://www.ncbi.nlm.nih.gov/books/NBK542183/

Na SJ, Chung CR, Choi HJ, Cho YH, Sung K, Yang JH, et al. The effect of multidisciplinary extracorporeal membrane oxygenation team on clinical outcomes in patients with severe acute respiratory failure. Ann Intensive Care 2018;8(1):31.

Brodie D, Slutsky AS, Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review. JAMA 2019;322(6):557–68.

Extracorporeal Life Support Organization. ECLS Registry Report, International Summary (Internet). 2019 (cited 2023 Oct 4). Available from: https://www.elso.org/registry/internationalsummaryandreports.aspx

Vaquer S, de Haro C, Peruga P, Oliva JC, Artigas A. Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Ann Intensive Care 2017;7:51.

Downloads

Published

13-02-2024

Issue

Section

Case Reports

How to Cite

“Use of Venovenous (VV) Extracorporeal Membrane Oxygenation (ECMO) in Near-Fatal Asthma: A Case Series”. 2024. Multidisciplinary Respiratory Medicine 19 (1). https://doi.org/10.5826/mrm.2024.943.